Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/194.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Conjugate or complex > Conjugated via claimed linking group, bond, or coupling agent
Description: Subject matter involving a conjugate wherein one component is coupled to another via a linking group, a bond, or a coupling agent that is specifically identified in the claim(s) by chemical name or chemical structure.










Patents under this class:
1 2 3 4 5 6 7 8 9 10

Patent Number Title Of Patent Date Issued
8703148 Immunogenic composition Apr. 22, 2014
8685406 Compositions of and method of using heat shock protein peptides Apr. 1, 2014
8685670 Isolated chimeric proteins of modified lumazine synthase Apr. 1, 2014
8673293 Use of modified cells for the treatment of multiple sclerosis Mar. 18, 2014
8658180 Vaccines against influenza virus Feb. 25, 2014
8652484 Delivery system for cytotoxic drugs by bispecific antibody pretargeting Feb. 18, 2014
8647631 Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines Feb. 11, 2014
8642011 Tuberculosis vaccine Feb. 4, 2014
8623378 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof Jan. 7, 2014
8604127 Conjugate of catechol-modified polyethylene glycol with protein or peptide and preparation method thereof Dec. 10, 2013
8603487 Palmitoylated AB 1-15 in a liposome as a treatment for amyloid associated diseases Dec. 10, 2013
8597634 Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof Dec. 3, 2013
8597635 Interferon alpha-2B modified by polyethylene glycol and methods of preparation thereof Dec. 3, 2013
8598324 Anti-pathogen treatments Dec. 3, 2013
8529899 Human growth hormone immunoglobulin fusion proteins Sep. 10, 2013
8513392 Conjugation of streptococcal capsular saccharides Aug. 20, 2013
8481048 Methods for preparing immunogenic conjugates Jul. 9, 2013
8475801 IgE CH3 peptide vaccine Jul. 2, 2013
8470333 Chimeric peptides comprising HER-2 B-cell epitopes and T-helper epitopes Jun. 25, 2013
8444996 Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia May. 21, 2013
8440206 Methods for producing an immune response to tuberculosis May. 14, 2013
8425915 Nanoparticles for providing immune responses against infectious agents Apr. 23, 2013
8409589 Mutant forms of streptolysin O Apr. 2, 2013
8388976 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor Mar. 5, 2013
8372388 Method for preparing a stable TNF-.alpha. vaccine Feb. 12, 2013
8357375 Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction Jan. 22, 2013
8357374 Conjugates of synthetic TLR agonists and uses therefor Jan. 22, 2013
8337863 Anti-sepsis conjugate vaccine Dec. 25, 2012
8329191 Three-branched polyethylene glycol-G-CSF conjugate Dec. 11, 2012
8298547 IgE CH3 peptide vaccine Oct. 30, 2012
8278278 Cell proliferation reducing cancer specific PCNA peptides Oct. 2, 2012
8268322 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor Sep. 18, 2012
8252288 Methods of using multimeric complexes of antigens and an adjuvant Aug. 28, 2012
8236321 Chemically programmable immunity Aug. 7, 2012
8221770 Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis Jul. 17, 2012
8202520 Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine Jun. 19, 2012
8192743 Releasable polymeric conjugates based on aliphatic biodegradable linkers Jun. 5, 2012
8187607 Hapten-carrier conjugates and uses thereof May. 29, 2012
8183338 Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof May. 22, 2012
8173601 Activin-ActRIIa antagonists and uses for treating multiple myeloma May. 8, 2012
8168195 Vaccines against Escherichia coli O157 infection May. 1, 2012
8153114 Hyperglycosylated mammalian IL-7 IgG conjugate composition Apr. 10, 2012
8153140 Chimeric MSP-based malaria vaccine Apr. 10, 2012
8128942 Anti-sepsis conjugate vaccine Mar. 6, 2012
8124590 Biodegradable immunomodulatory formulations and methods for use thereof Feb. 28, 2012
8105608 Method of treatment using ligand-immunogen conjugates Jan. 31, 2012
8092805 Dual inhibitors of HIV-1 gp-120 interactions Jan. 10, 2012
8093046 CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions Jan. 10, 2012
8088884 Multi-armed forms of activated polyoxazoline and methods of synthesis thereof Jan. 3, 2012
8080254 OB fusion protein compositions and methods Dec. 20, 2011

1 2 3 4 5 6 7 8 9 10










 
 
  Recently Added Patents
Estimating stack distances
Image enhancement based on multiple frames and motion estimation
Developing device
Semiconductor device
Mobile communication apparatus
Tracking data eye operating margin for steady state adaptation
Moving structure and micro-mirror device using the same
  Randomly Featured Patents
Y and T-finned tubes and methods and apparatus for their making
Carrier clip apparatus for linear linkless ammunition systems
Submersible chamber water heater
Semiconductor-type laminated ceramic capacitor with a grain boundary-insulated structure and a method for producing the same
LED lamp
Semiconductor device having step gates and method for fabricating the same
Resolution of glycidyl esters to high enantiomeric excess
Authentication using physical characteristics of tokens
Faucet spout
Pulse valve